Syndax Pharmaceuticals (NASDAQ:SNDX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?

Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Syndax Pharmaceuticals Stock (NASDAQ: SNDX) stock price, news, charts, stock research, profile.

Open	$18.56
Close	-
Volume / Avg.	307.75K / 1.05M
Day Range	$18.04 - $18.65
52 Wk Range	11.22 - 25.34
Market Cap	$1.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.46%
Days to Cover	8.13

Recent News

FDA Approves Incyte/Syndax Partnered Drug For Chronic Graft-Versus-Host Disease, A Post-Transplant Complication

The FDA has approved Incyte and Syndax Pharmaceuticals' Niktimvo for chronic graft-versus-host disease in patients after at least two prior therapies, providing new hope for those with this serious post-transplant condition.

Vandana Singh

Why Ooma Shares Are Trading Higher By Around 17%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

What's Going On With Leukemia-Focused Syndax Pharmaceuticals Stock Today?

Syndax Pharmaceuticals Inc (NASDAQ: SNDX) shares are trading higher after the company shared data from multiple trials of revumenib in combination with standard-of-care agents in patients with nucleophosmin mutant (mNPM1) and KMT2A-rearranged (KMT2r) relapsed/refractory

Vandana Singh

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

May

Jun

Jul

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.6

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$18.56
Close	-
Volume / Avg.	307.75K / 1.05M
Day Range	$18.04 - $18.65
52 Wk Range	11.22 - 25.34
Market Cap	$1.54B
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	39
Short Interest	11.46%
Days to Cover	8.13

About Syndax Pharmaceuticals Inc

Sector

Health Care

Industry

Biotechnology

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pip...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Syndax Pharmaceuticals (SNDX) stock?

You can purchase shares of Syndax Pharmaceuticals (NASDAQ:SNDX) through any online brokerage.

View our list of the best stock brokerages

Who are Syndax Pharmaceuticals (SNDX) competitors?

Other companies in Syndax Pharmaceuticals’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Centessa Pharmaceuticals (NASDAQ:CNTA), CareDx (NASDAQ:CDNA), Day One Biopharmaceutical (NASDAQ:DAWN) and Xencor (NASDAQ:XNCR).

What is the forecast, or price target, for Syndax Pharmaceuticals (SNDX) stock?

Syndax Pharmaceuticals has a consensus price target of $34.31.

What is the current price for Syndax Pharmaceuticals (SNDX)?

The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $18.095 last updated September 25, 2024 at 1:55 PM EDT.

Does Syndax Pharmaceuticals (SNDX) pay a dividend?

There are no upcoming dividends for Syndax Pharmaceuticals.

When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?

Syndax Pharmaceuticals’s Q3 earnings are confirmed for Thursday, October 31, 2024.

Is Syndax Pharmaceuticals (SNDX) going to split?

There is no upcoming split for Syndax Pharmaceuticals.

What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?

Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

Top Stock Ideas Sent Daily — Join and Gain Your Edge